eric karpinski

Eric Karpinski is a positive psychlogy keynote speaker and corporate trainer. In his Science of Happiness at Work program, he shares powerful positive psychology research that shows that happiness leads to success. He teaches executives, managers and employees how to become happier themselves and tap into higher productivity, more engagement and stronger relationships at work and at home. Managers and employees learn how to integrate simple processes into their work routines that ripple that happiness out to their teams, departments and entire companies.

POTENTIA is a developmentally designed e-learning platform that trains every area of psychological, social, and emotional well-being. Want to be smarter? We’ve got that covered. Emotional agility? We’ve got courses for that, too. Perhaps you want to be more resilient, or maybe you just want to find sustainable happiness or meaning in your life. Wherever you are now, and wherever you want to go—from building foundational interpersonal skills, to maximizing your cognitive potential—we have courses that can take you there. Every one of our courses is based on current research in psychology and neuroscience and developed in collaboration with leading academic researchers from around the world. https://potentiaapp.com/

Providing strategy and venture financing consulting to entrepreneurial biotechnology clients leveraging 15 years of venture capital, strategy consulting and operating experience in the biotech and pharma industry.

Led business development and strategic planning for Domain Associated funded virtual drug development company in the cardiovascular space.

* Life science venture firm with almost $500M under management. Drove due diligence * negotiated terms * closed financings * monitored and advised portfolio companies including: * Hypnion * sold to Eli Lilly for $315M * Novacardia * sold to Merck for $350M * Morphotek * sold to Eisai for $325M and * Conforma * sold to Biogen-Idec for $250M

Business Development summer intern for one of the most active biotech licensing companies in the world.

Worked with management team of a 60-person biopharmaceutical company with a market cap of ~$150M

Worked with international pharmaceutical firms including Ciba-Geigy (Novartis), Abbott and Astra-Merck to optimize R&D portfolios, value development projects and create in-licensing strategies.